Clinical Trial Update: Zoledronic Acid Compared to Percutaneous Treatment in Osteoid Osteoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing zoledronic acid to percutaneous treatment in osteoid osteoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoid Osteoma

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Osteoid Osteoma | Phase 3 | Status: TERMINATED